Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Episenta 500 mg Prolonged-release Granules {equilateral_black_triangle}

Active Ingredient:
sodium valproate
Company:  
Desitin Pharma Ltd See contact details
ATC code: 
N03AG01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Valproate DHPC for non-dispensing HCPs

{healthcare_pro_orange} For Healthcare Professionals
Direct Healthcare Professional Communication for HCPs (non-dispensing) providing background to the updates to the requirements for oral valproate-containing medicines.
{pdf_link}

Valproate DHPC for Pharmacists

{healthcare_pro_orange} For Healthcare Professionals
Direct Healthcare Professional Communication for pharmacists providing background to the updates to the requirements for oral valproate-containing medicines.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Desitin Pharma Ltd
Company image
Address
Fairbourne Drive, Atterbury, Milton Keynes, Bucks, MK10 9RG, UK
Telephone
+44 (0) 1908 488817
Medical Information Direct Line
+44 (0) 1908 488817
E-mail
[email protected]
WWW
www.desitin.co.uk